Inhibiting epigenetic enzymes to improve atherogenic macrophage functions

Biochemical and Biophysical Research Communications

Volumn 455, Issue 3-4, 2014, Pages 396-402

  Van Den Bossche, Jan ^a   Neele, Annette E ^a   Hoeksema, Marten A ^a   De Heij, Femke ^a   Boshuizen, Marieke C S ^a   Van Der Velden, Saskia ^a   De Boer, Vincent C ^a   Reedquist, Kris A ^b   De Winther, Menno P J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atherosclerosis; Chromatin modifying enzymes (CME); Epigenetics; Histone deacetylases (HDACs); Inflammation; Macrophages

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; CHROMATIN MODIFYING ENZYME; ENZYME; GIVINOSTAT; HISTONE DEACETYLASE 3; HISTONE METHYLTRANSFERASE; TRICHOSTATIN A; UNCLASSIFIED DRUG; CHROMATIN; HISTONE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BONE MARROW DERIVED MACROPHAGE; CELL METABOLISM; CELL PROTECTION; CONTROLLED STUDY; ENZYME INHIBITION; EPIGENETICS; FOAM CELL; GENE EXPRESSION; GLYCOLYSIS; HIGH THROUGHPUT SCREENING; HISTONE ACETYLATION; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; QUANTITATIVE ANALYSIS; ACETYLATION; ANIMAL; C57BL MOUSE; CELL LINE; CHEMISTRY; CHROMATIN; CYTOLOGY; FEMUR; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; MACROPHAGE; METABOLISM; PHENOTYPE; TIBIA;

ACETYLATION; ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; CELL LINE; CHROMATIN; EPIGENESIS, GENETIC; FEMUR; FOAM CELLS; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HISTONES; MACROPHAGES; MICE; MICE, INBRED C57BL; PHENOTYPE; TIBIA;

EID: 84914121575     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.11.029     Document Type: Article

References (32)

1. K.J. Moore, F.J. Sheedy, and E.A. Fisher Macrophages in atherosclerosis: a dynamic balance Nat. Rev. 13 2013 709 721
2. C. Silvestre-Roig, M.P. de Winther, and C. Weber Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies Circ. Res. 114 2014 214 226
3. M.A. Hoeksema, J.L. Stoger, and M.P. de Winther Molecular pathways regulating macrophage polarization: implications for atherosclerosis Curr. Atheroscler. Rep. 14 2012 254 263
4. J. Van den Bossche, W.H. Lamers, and E.S. Koehler Pivotal advance: arginase-1-independent polyamine production stimulates the expression of IL-4-induced alternatively activated macrophage markers while inhibiting LPS-induced expression of inflammatory genes J. Leukoc. Biol. 91 2012 685 699
5. A. Kadl, A.K. Meher, and P.R. Sharma Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2 Circ. Res. 107 2011 737 746
6. L.B. Ivashkiv Epigenetic regulation of macrophage polarization and function Trends Immunol. 34 2013 216 223
7. J. Van den Bossche, A.E. Neele, and M.A. Hoeksema Macrophage polarization: the epigenetic point of view Curr. Opin. Lipidol. 25 2014 367 373
8. S.B. Han, and J.K. Lee Anti-inflammatory effect of trichostatin-A on murine bone marrow-derived macrophages Arch. Pharm. Res. 32 2009 613 624
9. K.C. Choi, M.G. Jung, and Y.H. Lee Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation Cancer Res. 69 2009 583 592
10. V. Cortez, M. Mann, and S. Tekmal Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer Breast Cancer Res. 14 2012 R108
11. J. Kleinnijenhuis, J. Quintin, and F. Preijers Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes Proc. Natl. Acad. Sci. U.S.A. 109 2012 17537 17542
12. R. Glauben, A. Batra, and T. Stroh Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice Gut 57 2008 613 622
13. C.C. Allain, L.S. Poon, and C.S. Chan Enzymatic determination of total serum cholesterol Clin. Chem. 20 1974 470 475
14. M.A. Hoeksema, M.J. Gijbels, and J. Van den Bossche Targeting macrophage histone deacetylase 3 stabilizes atherosclerotic lesions EMBO Mol. Med. 6 2014 1124 1132
15. J. Van den Bossche, B. Malissen, and A. Mantovani Regulation and function of the E-cadherin/catenin complex in cells of the monocyte-macrophage lineage and DCs Blood 119 2012 1623 1633
16. M. Kobayashi, M. Nishizawa, and N. Inoue Epigallocatechin gallate decreases the micellar solubility of cholesterol via specific interaction with phosphatidylcholine J. Agric. Food Chem. 62 2014 2881 2890
17. S. Tavakoli, D. Zamora, and S. Ullevig Bioenergetic profiles diverge during macrophage polarization: implications for the interpretation of 18F-FDG PET imaging of atherosclerosis J. Nucl. Med. 54 2013 1661 1667
18. G.M. Tannahill, A.M. Curtis, and J. Adamik Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha Nature 496 2013 238 242
19. D. Vats, L. Mukundan, and J.I. Odegaard Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation Cell Metab. 4 2006 13 24
20. J.H. Choi, K.H. Nam, and J. Kim Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice Arterioscler. Thromb. Vasc. Biol. 25 2005 2404 2409
21. T. Roger, J. Lugrin, and R.D. Le Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection Blood 117 2011 1205 1217
22. M.A. Halili, M.R. Andrews, and L.I. Labzin Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS J. Leukoc. Biol. 87 2010 1103 1114
23. L. Klampfer, J. Huang, and L.A. Swaby Requirement of histone deacetylase activity for signaling by STAT1 J. Biol. Chem. 279 2004 30358 30368
24. X. Chen, G.M. El, and B.K. Yoza The NF-kappaB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance J. Biol. Chem. 284 2009 27857 27865
25. X. Wang, K. Zhu, and S. Li MLL1, a H3K4 methyltransferase, regulates the TNFalpha-stimulated activation of genes downstream of NF-kappaB J. Cell Sci. 125 2012 4058 4066
26. J. Van den Bossche, P. Bogaert, and J. van Hengel Alternatively activated macrophages engage in homotypic and heterotypic interactions through IL-4 and polyamine-induced E-cadherin/catenin complexes Blood 114 2009 4664 4674
27. N. Serrat, S. Pereira-Lopes, and M. Comalada Deacetylation of C/EBPbeta is required for IL-4-induced arginase-1 expression in murine macrophages Eur. J. Immunol. 42 2012 3028 3037
28. B. Wang, X. Zhu, and Y. Kim Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage Free Radical Biol. Med. 52 2012 928 936
29. F. Correa, C. Mallard, and M. Nilsson Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3beta Neurobiol. Dis. 44 2011 142 151
30. C.S. Ku, Y. Park, and S.L. Coleman Unsaturated fatty acids repress expression of ATP binding cassette transporter A1 and G1 in RAW 264.7 macrophages J. Nutr. Biochem. 23 2012 1271 1276
31. Y. Xu, Y. Xu, and Y. Bao Identification of dehydroxytrichostatin A as a novel up-regulator of the ATP-binding cassette transporter A1 (ABCA1) Molecules 16 2011 7183 7198
32. Q. Cao, S. Rong, and J.J. Repa Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development Arterioscler. Thromb. Vasc. Biol. 34 2014 1871 1879